文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

快速序贯器官衰竭评估评分预测脓毒症死亡率的准确性:纳入121项研究、1,716,017例个体的系统评价与Meta分析

Accuracy of Quick Sequential Organ Failure Assessment Score to Predict Sepsis Mortality in 121 Studies Including 1,716,017 Individuals: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Explor · 2019-09-17
一句话结论在预测脓毒症结局方面,快速序贯器官衰竭评估评分(qSOFA)总体优于全身炎症反应综合征(SIRS)标准,但qSOFA特异性更高而敏感性更低。

该Meta分析纳入121项研究、共1,716,017例个体,评估qSOFA评分对脓毒症结局的预测价值,并与SIRS标准比较。主要终点死亡率预测的合并曲线下面积(AUC):qSOFA为0.702(95%CI 0.685-0.718),SIRS为0.607(95%CI 0.589-0.624)。qSOFA在所有亚组分析中均优于SIRS(P<0.001)。qSOFA特异性74.58%高于SIRS的35.24%,但敏感性56.39%低于SIRS的78.84%。结论:qSOFA预测脓毒症结局优于SIRS,但相对优势/劣势为特异性更高、敏感性更低。

要点

  • 在121项研究、1,716,017例个体中,qSOFA预测死亡率的合并AUC为0.702(95%CI 0.685-0.718),高于SIRS的0.607(95%CI 0.589-0.624),P<0.001。
  • qSOFA在所有预设亚组分析中均优于SIRS(P<0.001),包括急诊科与ICU人群、回顾性与前瞻性研究设计、发达国家与资源有限国家。
  • qSOFA特异性74.58%(95%CI 73.55-75.61%)高于SIRS的35.24%(95%CI 22.80-47.69%),但敏感性56.39%(95%CI 50.52-62.27%)低于SIRS的78.84%(95%CI 74.48-83.19%)。
  • qSOFA预测死亡率AUC的异质性I²=99.41%(P<0.001),SIRS的异质性I²=96.49%(P<0.001)。
  • 作者结论:qSOFA预测脓毒症结局总体优于SIRS,但相对优势/劣势为特异性更高而敏感性更低。

适用人群与场景

  • 纳入报告死亡率、器官功能障碍、入住ICU、通气支持或ICU延长停留结局,且预测性能以AUC、比值比、敏感性或特异性报告的研究。
  • 亚组分析涵盖急诊科与ICU人群、回顾性与前瞻性研究设计、发达国家与资源有限国家。

研究设计与关键结果

  • 系统评价与Meta分析,检索MEDLINE、Cochrane Library、Embase、Web of Science和Google Scholar(截至2019年3月1日),最终纳入121项研究、1,716,017例个体。
  • 主要终点死亡率预测:qSOFA合并AUC为0.702(95%CI 0.685-0.718;I²=99.41%;P<0.001),SIRS合并AUC为0.607(95%CI 0.589-0.624;I²=96.49%;P<0.001)。
  • qSOFA在所有亚组分析中均优于SIRS(qSOFA的AUC vs SIRS的AUC,P<0.001)。
  • qSOFA特异性74.58%(95%CI 73.55-75.61%)高于SIRS特异性35.24%(95%CI 22.80-47.69%);qSOFA敏感性56.39%(95%CI 50.52-62.27%)低于SIRS敏感性78.84%(95%CI 74.48-83.19%)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析(PROSPERO注册号CRD42018103327)。
  • 采用随机效应模型进行数据合并,使用预设亚组分析探索异质性。
  • 局限:qSOFA预测死亡率AUC的异质性I²=99.41%(P<0.001),SIRS的异质性I²=96.49%(P<0.001);原文未报告其他局限性。

对床旁实践的改变

  • 作者认为,qSOFA预测脓毒症结局总体优于SIRS,但qSOFA与SIRS相比特异性更高而敏感性更低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: We performed a meta-analysis to assess whether the newly introduced quick Sequential Organ Failure Assessment score could predict sepsis outcomes and compared its performance to systematic inflammatory response syndrome, the previously widely used screening criteria for sepsis.

DATA SOURCES: We searched multiple electronic databases including MEDLINE, the Cochrane Library, Embase, Web of Science, and Google Scholar (up to March 1, 2019) that evaluated quick Sequential Organ Failure Assessment score, systemic inflammatory response syndrome, or both (International Prospective Register of Systematic Reviews [PROSPERO]: CRD42018103327).

STUDY SELECTION: Studies were included if the outcome was mortality, organ dysfunction, admission to ICU, ventilatory support, or prolonged ICU stay and if prediction performance was reported as either area under the curve, odds ratio, sensitivity, or specificity.

DATA EXTRACTION: The criterion validity of the quick Sequential Organ Failure Assessment score and systemic inflammatory response syndrome criteria were assessed by measuring its predictive validity for primary (mortality) and secondary outcomes in pooled metrics as mentioned. The data were analyzed using random effects model, and heterogeneity was explored using prespecified subgroups analyses.

DATA SYNTHESIS: We screened 1,340 studies, of which 121 studies (including data for 1,716,017 individuals) were analyzed. For mortality prediction, the pooled area under the curve was higher for quick Sequential Organ Failure Assessment score (0.702; 95% CI, 0.685-0.718; I 2 = 99.41%; p < 0.001) than for systemic inflammatory response syndrome (0.607; 95% CI, 0.589-0.624; I 2 = 96.49%; p < 0.001). Quick Sequential Organ Failure Assessment score consistently outperformed systemic inflammatory response syndrome across all subgroup analyses (area under the curve of quick Sequential Organ Failure Assessment vs. area under the curve of systemic inflammatory response syndrome p < 0.001), including patient populations (emergency department vs ICU), study design (retrospective vs prospective), and countries (developed vs resource-limited). Quick Sequential Organ Failure Assessment score was more specific (specificity, 74.58%; 95% CI, 73.55-75.61%) than systemic inflammatory response syndrome (specificity, 35.24%; 95% CI, 22.80-47.69%) but less sensitive (56.39%; 95% CI, 50.52-62.27%) than systemic inflammatory response syndrome (78.84%; 95% CI, 74.48-83.19%).

CONCLUSIONS: Overall, quick Sequential Organ Failure Assessment score outperforms systemic inflammatory response syndrome in predicting sepsis outcome, but quick Sequential Organ Failure Assessment score has relative strengths/weaknesses (more specific but less sensitive) compared with systemic inflammatory response syndrome.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Herwanto V, Shetty A, Nalos M, et al. Accuracy of Quick Sequential Organ Failure Assessment Score to Predict Sepsis Mortality in 121 Studies Including 1,716,017 Individuals: A Systematic Review and Meta-Analysis. Crit Care Explor. 2019. PMID: 32166285. doi:10.1097/CCE.0000000000000043

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。